CVS Health Corp. (CVS) Stock Grade

About CVS Health Corp.'s fundamentals

CVS Health generated revenue growth of 7.9% year-over-year, demonstrating modest expansion in its healthcare plans and related operations within a $100.5 billion market capitalization. However, the company operates with a very thin net margin of 0.4%, indicating that after all expenses, only a small fraction of each revenue dollar translates to profit. The return on equity stands at 2.4%, suggesting limited efficiency in generating returns from shareholder capital, while the valuation appears elevated at a P/E ratio of 56.9 relative to current earnings. The stock offers a 3.4% dividend yield, which may appeal to income-focused investors despite the underlying profitability constraints.